Delivery Order SPE2DB20D2104-SPE2DB25FMUWF

Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEVYE 0.1% EYE DROP 2ML, a medical product, with a ceiling value of $2,738.43 and a period of performance through May 13, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,564.51 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567039243 ! VEVYE 0.1% EYE DROP 2ML, with a period of performance through January 27, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,214.18, is for the procurement of VEVYE 0.1% eye drops in 2ml units. The contract has a firm fixed price pricing type and an ultimate completion date of May 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,587.78, is for the delivery of a specific pharmaceutical product, VEVYE 0.1% Eye Drop 2ML, with a completion date of April 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,010.02, is for the supply of a 0.1% eye drop medication (VEVYE 2ML). The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,031.27, is for the supply of 4567556748 ! VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,083.16 fixed-price delivery order is for the supply of a specific pharmaceutical product, VEVYE 0.1% eye drops, with a performance period ending on May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of 4568636254 ! VEVYE 0.1% EYE DROP 2ML, with a ceiling value of $3,281.59 and a period of performance through June 26, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.59, is for the delivery of a pharmaceutical product called "4567557411 ! VEVYE 0.1% EYE DROP 2ML". The contract is a Firm Fixed Price Delivery Order with a period of performance through March 13, 2025. There is no set-aside designation for this award. The contract is part of a larger...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMUWF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEVYE 0.1% eye drops (2 milliliters) and has a ceiling value of $1,186.03. The contract is not set aside and has an ultimate completion date of July 8, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 10/6/25, 12:43 PM